Evidence profile · Growth Hormoneresearch use only
§Evidence profile · Growth Hormone
Ipamorelin
A selective GH secretagogue studied for its clean receptor profile in preclinical models.
Evidence grade: Emerging
What Ipamorelin is
Ipamorelin is a selective growth-hormone secretagogue noted in preclinical work for stimulating GH release with relatively little effect on cortisol or prolactin. Human data are limited.
Mechanism (preclinical)
Selectively agonizes the ghrelin/GH-secretagogue receptor to trigger GH release.
Primary research areas
GH pulse stimulationReceptor selectivityBody-composition models
Selected studies
Selective GH release (preclinical)
1998GH increase without significant cortisol/prolactin rise.
Regulatory status
Not FDA-approved. Sold for laboratory research use only.
If you source Ipamorelin for laboratory research
Buy only from a vendor that publishes a lot-matched COA from an independent laboratory. Check the lot number on the vial against the certificate. Read the HPLC result and the mass spectrometry result. Ask for the chromatogram.